Russian Foreign Minister Sergey Lavrov said today that his country and India are studying the start of joint production of the Sputnik V vaccine against Covid-19 in the Asian nation on an industrial scale.
In a joint press conference with the Indian Foreign Minister, Subrahmanyam Jaishankar, the Russian diplomat stressed that in the confrontation with the SARS-CoV-2 coronavirus "we have already done a lot," said the TASS news agency.
The minister recalled that the Russian Direct Investment Fund concluded agreements with the main pharmaceutical companies in India to produce Sputnik V and stressed that they had already manufactured the first test batches in that country.
"Now the relevant structures are agreeing on how to do it on an industrial scale," Lavrov clarified. He said that the production of the drug in India will contribute "significantly" to the global efforts to end the pandemic.
He also expressed that Russia is willing to analyze with India the possibilities of coordinating actions for the certification of vaccinated people. "I think this agreement is quite achievable, it will be an example for other countries," he said.
According to Prensa Latina, the Foreign Minister described the relations between Russia and India as exemplary in the field of cooperation in the fight against the coronavirus.
He stressed that Moscow and New Delhi oppose the politicization of the vaccine issue, in the face of "attempts to be guided by considerations of unfair competition," the diplomat emphasized.
For the Indian Foreign Minister, the challenge caused by the pandemic allowed to demonstrate the strength of the interaction between Russia and India.
In Moscow, Jaishankar also met with Leonid Slutski, chairman of the International Affairs Committee of the State Duma (lower house), to whom he expressed his country's gratitude to Russia for the assistance provided in the fight against Covid-19.
During the meeting, the Indian Chancellor meant that his country began the production of the Sputnik V vaccine against the SARS-CoV-2 coronavirus and reported that in the near future it will be ready to reach a volume of 850 million doses of vaccines per year.